These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8913713)

  • 1. How do calcium channel blockers prevent cardiovascular events. Are they all alike?
    Bogaert MG
    Drugs; 1996; 52 Suppl 4():3-7; discussion 7-8. PubMed ID: 8913713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists as cardioprotective agents.
    Frohlich ED
    Am J Cardiol; 1992 Dec; 70(21):7I-9I. PubMed ID: 1471604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers].
    Takahara A
    Clin Calcium; 2010 Jan; 20(1):24-30. PubMed ID: 20048430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers.
    Hurwitz CU
    CRNA; 1996 Feb; 7(1):29-32. PubMed ID: 8680353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiatherosclerotic hopes of calcium channel blockers].
    Uetake Y; Shimosawa T
    Clin Calcium; 2005 Oct; 15(10):1689-94. PubMed ID: 16199916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative clinical pharmacology of calcium channel blockers.
    Kim KE
    Am Fam Physician; 1991 Feb; 43(2):583-8. PubMed ID: 1990741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium channel blockers (calcium antagonists). Background, effects and use].
    Mikkelsen EO
    Ugeskr Laeger; 1995 Jun; 157(26):3750-4. PubMed ID: 7631450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and EBM].
    Toba A; Kuwajima I
    Clin Calcium; 2010 Jan; 20(1):9-15. PubMed ID: 20048428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiatherosclerotic and vasculoprotective effects of calcium antagonists: clinical implications.
    Ram CV
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():35-9. PubMed ID: 2090836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Large scale clinical trials of calcium channel blockers on the prevention of cardiovascular diseases].
    Shimamoto K
    Clin Calcium; 2005 Oct; 15(10):1609-14. PubMed ID: 16199905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perspective of calcium antagonist].
    Kim-Mitsuyama S
    Clin Calcium; 2005 Jan; 15(1):81-6. PubMed ID: 15632476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of calcium entry blockers into calcium channel blockers and calcium overload blockers.
    van Zwieten PA
    Eur Neurol; 1986; 25 Suppl 1():57-67. PubMed ID: 3758108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
    Freedman DD; Waters DD
    Drugs; 1987 Nov; 34(5):578-98. PubMed ID: 3319491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine.
    Opie LH
    Postgrad Med J; 1991; 67 Suppl 5():S2-8. PubMed ID: 1666430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage].
    Fujino T; Sumitomo K; Hasebe N; Kikuchi K
    Clin Calcium; 2004 Jan; 14(1):119-27. PubMed ID: 15576967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridine calcium channel antagonists in the management of hypertension.
    Epstein BJ; Vogel K; Palmer BF
    Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.